QSAR Classification Modeling for Bioactivity of Molecular Structure via SPL-Logsum
Quantitative structure-activity relationship (QSAR) modelling is effective 'bridge' to search the reliable relationship related bioactivity to molecular structure. A QSAR classification model contains a lager number of redundant, noisy and irrelevant descriptors. To address this problem, various of methods have been proposed for descriptor selection. Generally, they can be grouped into three categories: filters, wrappers, and embedded methods. Regularization method is an important embedded technology, which can be used for continuous shrinkage and automatic descriptors selection. In recent years, the interest of researchers in the application of regularization techniques is increasing in descriptors selection , such as, logistic regression(LR) with $L_1$ penalty. In this paper, we proposed a novel descriptor selection method based on self-paced learning(SPL) with Logsum penalized LR for predicting the bioactivity of molecular structure. SPL inspired by the learning process of humans and animals that gradually learns from easy samples(smaller losses) to hard samples(bigger losses) samples into training and Logsum regularization has capacity to select few meaningful and significant molecular descriptors, respectively. Experimental results on simulation and three public QSAR datasets show that our proposed SPL-Logsum method outperforms other commonly used sparse methods in terms of classification performance and model interpretation.
Code (0)
등록된 구현이 없습니다.
Tasks
General ClassificationSimilar Papers 제목 키워드 기반
Investigating 3D Atomic Environments for Enhanced QSAR
Predicting bioactivity and physical properties of molecules is a longstanding challenge in drug design. Most approaches use molecular descriptors based on a 2D representation of molecules as a graph of atoms and bonds, a…
Drug DesignBioMiner: A Multi-modal System for Automated Mining of Protein-Ligand Bioactivity Data from Literature
Protein-ligand bioactivity data published in the literature are essential for drug discovery, yet manual curation struggles to keep pace with rapidly growing literature. Automated bioactivity extraction remains challengi…
Drug DiscoveryAtomNet: A Deep Convolutional Neural Network for Bioactivity Prediction in Structure-based Drug Discovery
Deep convolutional neural networks comprise a subclass of deep neural networks (DNN) with a constrained architecture that leverages the spatial and temporal structure of the domain they model. Convolutional networks achi…
Drug DiscoveryQuantum QSAR for drug discovery
Quantitative Structure-Activity Relationship (QSAR) modeling is key in drug discovery, but classical methods face limitations when handling high-dimensional data and capturing complex molecular interactions. This researc…
Drug DiscoveryPrediction of Novel CXCR7 Inhibitors Using QSAR Modeling and Validation via Molecular Docking
CXCR7, a G-protein-coupled chemokine receptor, has recently emerged as a key player in cancer progression, particularly in driving angiogenesis and metastasis. Despite its significance, currently, few effective inhibitor…
Molecular Docking